Derderian N, Pereira-Prado V, Hernandez M, Isiordia-Espinoza M, Arocena M, González-González R, et al. Ep-CAM (MOC-31) expression in tooth germ and ameloblastoma. Med Oral Patol Oral Cir Bucal. 2022 Sep 1;27 (5):e403-9.
doi:10.4317/medoral.25145
https://dx.doi.org/doi:10.4317/medoral.25145
1. Wright JM, Odell EW, Speight PM, Takata T. Odontogenic tumors, WHO 2005: where do we go from here?. Head Neck Pathol. 2014;8:373-82. |
PMid:25409849 PMCid:PMC4245407 |
2. Hendra FN, Van Cann EM, Helder MN, Ruslin M, de Visscher JG, Forouzanfar T, et al. Global inci-dence and profile of ameloblastoma: A systematic review and meta‐analysis. Oral Dis. 2020;26:12-21. |
PMid:30614154 |
3. De Medeiros WK, Da Silva LP, Santos PP, Pinto LP, de Souza LB. Clinicopathological analysis of odontogenic tumors over 22 years period: Experience of a single center in northeastern Brazil. Med Oral Patol Oral Cir Bucal. 2018;23:664-71. |
PMid:30341267 PMCid:PMC6261000 |
4. Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current etiopathological concepts and management. Oral Dis. 2018;24:307-16. |
PMid:28142213 |
5. Wright JM, Vered M. Update from the 4th Edition of the World HealthOrganization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. Head Neck Pathol. 2017;11:68-77. |
PMid:28247226 PMCid:PMC5340735 |
6. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, et al. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol. 2009;11:162-71. |
PMid:19136966 |
7. Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). J Mol Med (Berl). 1999;77:699-12. |
PMid:10606205 |
8. Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F, et al. Epithelial cell adhesion molecule (ep-cam) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol. 1997;139:1337-48. |
PMid:9382878 PMCid:PMC2140211 |
9. Trzpis M, McLaughlin P, De Leij L, Harmsen M. Epithelial Cell Adhesion Molecule: More than a Carcinoma Marker and Adhesion Molecule. Am J Pathol. 2007;171:386-95. |
PMid:17600130 PMCid:PMC1934518 |
10. Hwang EY, Yu CH, Cheng SJ, Chang JY, Chen HM, Chiang CP. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med. 2009;38:87-93. |
PMid:18355175 |
11. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, et al. Frequent EpCam protein ex-pression in human carcinomas. Hum Pathol. 2004;35:122-8. |
PMid:14745734 |
12. Gires O, Pan M, Schinke H, Canis M, Baeuerle PA. Expression and function of epithelial cell adhe-sion molecule EpCAM: Where are we after 40 years?. Cancer Metastasis Rev. 2020;39:969-87. |
PMid:32507912 PMCid:PMC7497325 |
13. Pan M, Schinke H, Luxenburger E, Kranz G, Shakhtour J, Libl D, et al. EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modula-tion of phospho-ERK1/2 in head and neck cancers. PLoS Biol. 2018;16:e2006624. |
PMid:30261040 PMCid:PMC6177200 |
14. Gosens MJ, Van Kempen LC, Van de Velde CJ, Van Krieken JH, Nagtegaal ID. Loss of membra-nous Ep-CAM in budding colorectal carcinoma cells. Mod Pathol. 2007;20:221-32. |
PMid:17361206 |
15. Wen KC, Sung PL, Chou YT, Pan CM, Wang PH, Lee OK, et al. The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma. Gynecol Oncol. 2018;148:383-92. |
PMid:29208367 |
16. López-Verdín S, Soto-Avila JJ, Zamora-Perez AL, Lazalde-Ramos BP, Martínez-Fierro ML, Gonzá-lez-González R, et al. Patients with advanced oral squamous cell carcinoma have high levels of soluble E-cadherin in the saliva. Med Oral Patol Oral Cir Bucal. 2017;22:e694-701. |
PMid:29053653 PMCid:PMC5813987 |
17. Edelman GM. A golden age for adhesion. Cell Adhes. Commun. 1993;1:1-7. |
PMid:8081869 |
18. Choi D, Lee HJ, Jee S, Jin S, Koo SK, Paik SS, et al. In vitro differentiation of mouse embryonic stem cells: enrichment of endodermal cells in the embryoid body. Stem Cells. 2005;23:817-27. |
PMid:15917477 |
19. Tarmann T, Dohr G, Schiechl H, Barth S, Hartmann M. Immunohistochemical detection of an epi-thelial membrane protein in rat embryos at different stages of development. Acta Anat (Basel). 1990;137:141-5. |
PMid:2180247 |
20. de Boer CJ, van Krieken JH, Janssen-van Rhijn CM, Litvinov SV. Expression of Ep-CAM in nor-mal, regenerating, metaplastic, and neoplastic liver. J Pathol. 1999;188:201-6. |
https://doi.org/10.1002/(SICI)1096-9896(199906)188:2<201::AID-PATH339>3.0.CO;2-8 |
PMid:10398165 |
21. González-González R, Molina-Frechero N, Damian-Matsumura P, Bologna-Molina R. Molecular markers of cell adhesion in ameloblastomas. An update. Med Oral Patol Oral Cir Bucal. 2014;19:8-14. |
PMid:23986011 PMCid:PMC3909437 |
22. Wang H, Stoecklein NH, Lin PP, Gires O. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion. Oncotarget. 2017;8:1884-912. |
PMid:27683128 PMCid:PMC5352105 |
23. Herreros-Pomares A, Aguilar-Gallardo C, Calabuig-Fariñas S, Sirera R, Jantus-Lewintre E, Camps C. EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale. Crit Rev Oncol Hema-tol. 2018;126:52-63. |
PMid:29759567 |
24. Wang YY, Li L, Zhao ZS, Wang YX, Ye ZY, Tao HQ. L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients. J Exp Clin Cancer Res. 2013;32:66. |
PMid:24422715 PMCid:PMC3850006 |
25. Woopen H, Pietzner K, Richter R, Fotopoulou C, Joens T, Braicu EI, et al. Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer. J Gynecol Oncol. 2014;25:221-8. |
PMid:25045435 PMCid:PMC4102741 |
26. Van der Gun BT, Melchers LJ, Ruiters MH, de Leij LF, McLaughlin PM, Rots MG. EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis. 2010;31:1913-21. |
PMid:20837599 |